Meta Biomed Co., Ltd. (KOSDAQ:059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,865.00
-10.00 (-0.26%)
At close: Sep 4, 2026

Meta Biomed Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
15,30717,95614,51710,79613,22610,113
Short-Term Investments
767.662,97313,0002,9704,4101,957
Trading Asset Securities
21,60816,93426,7813,0441,5053,846
Cash & Short-Term Investments
37,68337,86354,29816,81019,14115,916
Cash Growth
-22.57%-30.27%223.01%-12.18%20.26%-24.37%
Accounts Receivable
22,74817,96613,38112,88012,82212,409
Other Receivables
1,1981,8891,3791,6521,682636.92
Receivables
23,96219,88617,26114,53214,50413,046
Inventory
24,83523,27918,77515,40214,73415,276
Prepaid Expenses
594.7971.751,6781,9541,158100.45
Other Current Assets
930.02813.681,9451,2271,4391,322
Total Current Assets
88,00582,81493,95749,92450,97645,661
Property, Plant & Equipment
81,61076,90464,09959,08652,12339,278
Long-Term Investments
14,45513,2276,2327,1187,6877,365
Goodwill
-1,1071,0081,0082,023524.06
Other Intangible Assets
2,047955.44824.26675.57688.41783.26
Long-Term Deferred Tax Assets
5,3825,8026,1517,0804,7834,966
Long-Term Deferred Charges
-----70.9
Other Long-Term Assets
1,6163,7953,9661,804879.893,627
Total Assets
194,616186,604177,295130,124121,072103,128

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,7572,4712,6732,9232,4251,922
Accrued Expenses
2,7392,1441,4031,303910.411,121
Short-Term Debt
39,67137,36749,35330,97131,23024,830
Current Portion of Long-Term Debt
15.423,931299.33728.19948.685,532
Current Portion of Leases
328.51479.46435.83246.82145.81187.8
Current Income Taxes Payable
2,884724.38261.836.7510.142.1
Other Current Liabilities
9,07412,51319,1718,2939,1474,527
Total Current Liabilities
57,46859,63173,59744,47144,81738,161
Long-Term Debt
5,752735.85,60012,20711,6183,842
Long-Term Leases
162.5206.52434.4294.66128.7687.6
Pension & Post-Retirement Benefits
-00-00195.65
Long-Term Deferred Tax Liabilities
-----192.08
Other Long-Term Liabilities
857.641,1571,553489.031,069551.35
Total Liabilities
64,24061,73081,18557,46257,63343,030

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
14,04714,04711,93111,93111,93111,931
Additional Paid-In Capital
25,43955,22234,66634,66634,45534,455
Retained Earnings
91,32357,43147,12725,35915,81013,640
Treasury Stock
-2,836-2,982-2,982-2,842-2,842-2,778
Comprehensive Income & Other
2,012598.582,597933.391,2371,075
Total Common Equity
129,985124,31693,33970,04860,59158,323
Minority Interest
391.46557.032,7712,6142,8481,775
Shareholders' Equity
130,376124,87396,11072,66263,43960,099
Total Liabilities & Equity
194,616186,604177,295130,124121,072103,128

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
45,92942,72056,12344,44844,07234,478
Net Cash (Debt)
-8,246-4,857-1,824-27,638-24,931-18,562
Net Cash Growth
------
Net Cash Per Share
-287.10-193.45-67.29-1208.43-1089.37-810.54
Filing Date Shares Outstanding
26.9627.0622.8322.8722.8722.9
Total Common Shares Outstanding
26.9627.0622.8322.8722.8722.9
Working Capital
30,53723,18320,3605,4526,1587,499
Book Value Per Share
4822.204593.594088.233062.712649.242546.74
Tangible Book Value
127,938122,25491,50668,36457,87957,016
Tangible Book Value Per Share
4746.264517.384007.952989.082530.672489.66
Land
-9,1488,8936,1246,7686,727
Buildings
-45,83335,70434,81721,32220,924
Machinery
-54,73948,84247,58738,73734,361
Construction In Progress
-1,2451,4651,17811,993297.15